Regulatory considerations, challenges and risk-based approach in nanomedicine development
The translation of nanomedicines from the lab level into marketed product faces several challenges, including characterization of physicochemical properties, phar-macodynamics, pharmacokinetics, process control, biocompatibility, and nanotoxicity, scaling-up as well as reproducibility. The challenge...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2021
|
| Sorozat: | CURRENT MEDICINAL CHEMISTRY
28 No. 36 |
| Tárgyszavak: | |
| doi: | 10.2174/0929867328666210406115529 |
| mtmt: | 32506114 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/25483 |